ABT ▲ +1.3% - Abbott Laboratories $ABT - Abbott reaches agreement with Department of Justice to resolve claims relating to 2022 infant formula recall Abbott Laboratories shares rose 1.3% following news that the company reached an agreement with the Department of Justice to resolve claims tied to its 2022 infant formula recall. The settlement removes a significant legal overhang that had clouded the company's outlook since the recall disrupted the market and raised questions about Abbott's manufacturing practices. 14-SEP-2026 11:53 AM ET